Congress Takes Steps Toward Expanding Home Infusion Access
The 2026 government funding for Health and Human Services that passed the House of Representatives today includes a change to the qualifying criteria for drugs under Medicare’s home infusion benefit that may expand access to certain health care provider-administered drugs if an infusion pump is required for administration. Passage of H.R. 4993, the Joe Fiandra Access to Home Infusion Act, reflects Congress’ recognition of the strong patient interest—including among individuals with rare diseases—in home infusion access.
Jefferson Health, represented by Thomas Brown, Director of Health Ventures. Jefferson Health delivers care to the Delaware Valley through a network of 33 hospitals and physician practices. Jefferson Home Infusion Service has been a leading provider of home infusion therapies since 1986. Jefferson team members have been actively engaged with NHIA for more than 20 years, serving on committees, the Board of Directors, and participating in Capitol Hill days and other advocacy efforts. In addition, share their knowledge through NHIA educational programs, poster abstracts, and publications.